Alison M Moore

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma

D. LeBrun, S. Crocker, O. Moshkin, 2018, Diagnostic Pathology.

Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy

D. LeBrun, T. Baetz, D. Good, 2022, Leukemia & lymphoma.

Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and BCL2 gene alterations

Bingshu E. Chen, D. Scott, C. Steidl, 2020, Leukemia & lymphoma.